Extreme Aggressiveness and Lethality of Gastric Adenocarcinoma in the Very Young

Extreme Aggressiveness and Lethality of Gastric Adenocarcinoma in the Very Young
复制标题

DOI:
10.1001/archsurg.2009.77
复制
发表时间:
2009-06-01
影响因子:
--
通讯作者:
Stabile, Bruce E.
Stabile, Bruce E.
中科院分区:
其他
文献类型:
--
作者:
Smith, Brian R.;Stabile, Bruce E.

文献摘要

被引文献

相似文献

目的:确定非常年轻的胃腺癌患者与老年患者相比,是否具有生物学上更具侵袭性的疾病形式,出现在晚期,并赋予异常差的围手术期和长期预后。设计、环境和患者:对350例诊断为胃腺癌的患者进行为期15年、单机构、回顾性回顾和人口统计学和结局数据分析。主要观察指标:非常年轻和老年患者组的组织学特征、IV期疾病频率、治愈性胃切除术频率、术后死亡率和长期生存率。结果:在350例患者中,30例(9%)年龄在35岁或以下。非常年轻的患者(35岁)更常有弥漫性肿瘤组织学表现(分别为93%对69%,P= 0.003)、邻近器官侵犯(分别为74%对29%,P= 0.001)、淋巴结转移(分别为94%对70%,P= 0.046)、远处转移(分别为81%对50%,P= 0.003)和IV期疾病(分别为90%对64%,P= 0.003)。有治愈潜力的胃切除术在58%的老年患者中完成,但在非常年轻的患者中只有17% (P=.001)。只有6%的老年患者进行了非治疗性手术,但33%的非常年轻的患者进行了非治疗性手术(P= 0.002)。与老年患者相比,非常年轻的患者与晚期疾病相关的术后死亡率较高(分别为22%对2%;P= 0.003)。老年患者的平均生存期为33.4个月,而非常年轻的患者仅为11.6个月(P= 0.02)。结论:非常年轻的患者(年龄
Objective: To determine whether very young patients with gastric adenocarcinoma as compared with older patients with the disease have a biologically more aggressive form of the disease, presenting at an advanced stage and conferring unusually poor perioperative and long-term outcomes.Design, Setting, and Patients: A 15-year, single-institution, retrospective review and analysis of demographic and outcomes data for 350 patients diagnosed with gastric adenocarcinoma.Main Outcome Measures: Histologic features, frequency of stage IV disease, frequency of curative gastric resection, postoperative mortality, and long-term survival in very young and older patient groups.Results: Of 350 total patients, 30 (9%) were aged 35 years or younger. Very young patients (aged 35 years) more often had diffuse-type tumor histologic findings (93% vs 69%, respectively; P=.003), adjacent organ invasion (74% vs 29%, respectively; P=.001), nodal metastases (94% vs 70%, respectively; P=.046), distant metastases (81% vs 50%, respectively; P=.003), and stage IV disease (90% vs 64%, respectively; P=.007). Potentially curative gastrectomy was accomplished in 58% of older patients but only 17% of very young patients (P=.001). Nontherapeutic operations were performed in only 6% of older patients but 33% of very young patients (P=.002). Very young patients as compared with older patients had high postoperative mortality (22% vs 2%, respectively; P=.003) related to advanced- stage disease. Mean survival was 33.4 months among older patients compared with only 11.6 months for very young patients (P=.02).Conclusions: Very young patients (aged